Exodus Point Capital Management, LP Fulgent Genetics, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 52,579 shares of FLGT stock, worth $964,298. This represents 0.01% of its overall portfolio holdings.
Number of Shares
52,579
Previous 92,781
43.33%
Holding current value
$964,298
Previous $1.82 Million
37.2%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding FLGT
# of Institutions
200Shares Held
16MCall Options Held
2.04MPut Options Held
14K-
Black Rock Inc. New York, NY3.92MShares$71.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$26.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$23.3 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$20.3 Million0.01% of portfolio
-
State Street Corp Boston, MA794KShares$14.6 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $555M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...